Breaking News, Collaborations & Alliances

AGC Biologics Enters CDMO Partnership with Ono Pharmaceuticals

To manufacture biopharmaceuticals at clinical development stage.

By: Contract Pharma

Contract Pharma Staff

AGC Biologics, a global biopharmaceutical contract development and manufacturing organization (CDMO), is partnering with Ono Pharmaceutical Co., Ltd. to manufacture new biopharmaceuticals at the clinical development stage. ONO is a R&D-oriented pharmaceutical company committed to discovering and developing innovative drugs.   “We are very pleased to initiate this partnership with ONO,” said Mark Womack, CBO of AGC Biologics. “We look forward to closely collaborating with ON...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters